The role of surgery in advanced epithelial ovarian cancer.
Nowadays, the standard management of advanced epithelial ovarian cancer is correct surgical staging and optimal tumour cytoreduction followed by platinum and taxane-based chemotherapy. Standard surgical staging consists of peritoneal washings, total hysterectomy, and bilateral salpingo-oophorectomy, inspection of all abdominal organs and the peritoneal surface, biopsies of suspicious areas or randomised biopsies if they are not present, omentectomy and para-aortic lymphadenectomy. After this complete surgical staging, the International Federation of Gynaecology and Obstetrics (FIGO) staging system for ovarian cancer is applied to determine the management and prognosis of the patient. Complete tumour cytoreduction has shown an improvement in survival. There are some criteria to predict cytoreduction outcomes based on serum biomarkers levels, preoperative imaging techniques, and laparoscopic-based scores. Optimised patient selection for primary cytoreduction would determine patients who could benefit from an optimal cytoreduction and might benefit from interval surgery. The administration of intraperitoneal chemotherapy after debulking surgery has shown an increase in progression-free survival and overall survival, especially in patients with no residual disease after surgery. It is considered that 3-17% of all epithelial ovarian carcinoma (EOC) occur in young women that have not fulfilled their reproductive desires. In these patients, fertility-sparing surgery is a worthy option in early ovarian cancer.
Gynaecologic Oncology Unit, La Paz University Hospital, Madrid 28046, Spain.
María
M
Martín-Cameán
Gynaecologic Oncology Unit, La Paz University Hospital, Madrid 28046, Spain.
Elsa
E
Delgado-Sánchez
Gynaecologic Oncology Unit, La Paz University Hospital, Madrid 28046, Spain.
Antonio
A
Piñera
Gynaecologic Oncology Unit, La Paz University Hospital, Madrid 28046, Spain.
Maria Dolores
MD
Diestro
Gynaecologic Oncology Unit, La Paz University Hospital, Madrid 28046, Spain.
Javier
J
De Santiago
Gynaecologic Oncology Unit, La Paz University Hospital, Madrid 28046, Spain.
Ignacio
I
Zapardiel
cytoreduction; intraperitoneal chemotherapy; ovarian cancer; surgical treatment; treatment